Interview with Shikha Sharma, Senior Director, Innovation at California Life Sciences (CLS)

Shikha-SharmaShikha Sharma Interview with Shikha Sharma, Senior Director, Innovation at California Life Sciences

By Caitlin Dolegowski, Marketing Manager, LSN

CaitiCaitlin Dolegowski

Caitlin Dolegowski (CD): Please introduce us to California Life Sciences.

Shikha Sharma (SS): California Life Sciences (CLS) is the state’s most impactful life sciences membership organization, advocating for the sector and its diverse innovation pipeline. For more than 30 years, CLS has served the community by supporting companies of all sizes, from early-stage innovators and startups to established industry leaders in the fields of biotechnology, pharmaceuticals, and medical technology. As integral components of a healthy and collaborative ecosystem, CLS also works closely with universities, academic and research institutions, the investment community, and other critical partners that promote this vibrant sector. On behalf of our more than 1,200 member organizations, CLS works to shape public policy, improve access to breakthrough technologies, educate lawmakers, and advance equity within our ecosystem by championing innovative solutions for some of the most pressing challenges of our times. In doing so, CLS fulfills its mission to protect and nurture California’s life sciences industry, empowering discoveries that lead to healthier lives around the world.

CD: What type of companies do California Life Sciences consider for membership?

SS: CLS members represent companies of all sizes, from early-stage innovators and startups to established industry leaders in the fields of biotechnology, pharmaceuticals, and medical technology. As integral components of a healthy and collaborative ecosystem, CLS also works closely with universities, academic and research institutions, the investment community, and other critical partners that promote this vibrant sector.

CD: What stage of fundraising is California Life Sciences looking to support?

SS: The CLS Innovation & Entrepreneurship programs primarily support early-stage companies in fundraising stages from pre-seed to Series A. However, the broader CLS community encompasses members, companies, stakeholders, and pharma industry professionals with accessibility to later stage fundraising know-how and connections. Becoming part of CLS gives you access to a broad network that can directly and indirectly support companies in any stage of fundraising.

CD: Clearly, California Life Sciences, is in California. Though, not all your members are located in California. What are your geographic qualifications?

SS: We don’t have geographic qualifications, per se.  CLS welcomes any organization that is looking to access, expand and/or maintain a foothold in what I would consider the most robust life sciences ecosystem worldwide.

CD: What works well for California Life Sciences in being a part of the RESI experience?

SS: As part of our portfolio of entrepreneurship services, CLS seeks to establish partnerships with respected partnering and investor conferences to aid our members in the fundraising journeys. Importantly, opportunities like RESI connects them with Seed and Series B investors, channel and licensing partners.

CD: What other information is important for companies to consider about California Life Sciences?

SS:  California Life Sciences’ innovation and entrepreneurship initiatives connect life science startups to the resources needed to help them effectively scale their ventures. Our programs create a platform for accessing business partners, investors, foundations and patient advocacy organizations, peers, and other industry leaders.

Designed to nurture and advocate for emerging and diverse innovators from throughout the state, CLS offers advisory services, positioning for capital tools, access to capital through strategic partnerships and events and US market access resources to help in the development and commercialization of their business.

RESI-Boston-2023-September-1100px-w

Apply before August 9 and Join these Confirmed Companies at RESI September Innovator’s Pitch Challenge (IPC)

By Joey Wong, Investor Research Analyst, Hong Kong BD, LSN

Life Science Nation (LSN)’s next event, RESI September, is coming up on September 18. The conference will take place at the Boston Park Plaza, located in the heart of Boston – a hub of life science and healthcare innovation.

RESI has consistently provided an exceptional opportunity for entrepreneurs to pitch directly to a panel of active investors and industry experts through the Innovator’s Pitch Challenge (IPC). The IPC has rapidly gained popularity and has become the go-to event for many successful entrepreneurs to fine-tune their pitching skills, receive valuable feedback on their products and technologies and connect directly with seasoned investors.

During an IPC session, participating companies will be given 4 minutes for their presentation, followed by 9 minutes of Q&A. IPC’s unique format and judge recruitment process allows companies to pitch alongside fellow entrepreneurs operating in the same sectors and in front of a panel of investor pitch judges who are immensely experienced in that particular sector. By joining the IPC, companies gain not only significant exposure, but also invaluable connections with influential investors and industry experts.

We are excited to announce a selection of the confirmed companies that will be pitching at RESI September. Don’t forget to submit your application before the deadline on August 9 to join these companies at RESI September IPC.

Confirmed Pitch Companies
And More…

RESI-Boston-2023-September-1100px-w

Exhibiting at RESI Boston September 2023

By Greg Mannix, Vice President International Business Development, General Manager Europe, LSN

RESI is returning to Boston in September and will be in-person on September 18, with a hybrid digital component on September 19-20. The feedback from exhibitors at our recent conferences has been amazing. The opportunity to engage potential customers from the 300+ early-stage companies that attend RESI, plus the brand visibility, make RESI ideal for service providers catering to these companies, developing technologies in drugs, devices, diagnostics and digital health.

RESI offers different levels of sponsorship to service providers, who can target prospective clients and maximize their brand visibility. Options range from exhibiting at RESI to hosting a sponsored workshop during the conference.

RESI-Boston-2023-September-1100px-w

Enhancing Efficiency and Strategy of Investor Outreach

By Cameron Hurlburt, Manager of Business Development – West Coast (US), LSN

Life Science Nation (LSN) has implemented a new pricing model for our Investor and Licensing Partner Database. This database contains 3K+ investor firms, with specific interests in the early-stage life science sector, across 10 categories of investors* and licensing partners, including 10K+ contacts. Searches can be executed through specific filters including but not limited to, sector, subsector, indication, and phase of development. The information presented in the database is obtained directly from each company through 1:1 interviews with investor research analysts at LSN and updated regularly.  This is a valuable resource for companies looking to establish their Global Target List and execute their fundraising journey.

*10 categories of investors:

  • Angel Groups
  • Corporate Venture Capital
  • Endowments/Foundations
  • Family Office/Private Wealth Funds
  • Government Organizations
  • Hedge Funds
  • Institutional Alternative Investors
  • Large Pharma/ Biotech Companies
  • Private Equity
  • Venture Capital

The prior pricing model was $4.5K for 6 months or $7K for 1 year. Since most companies that wish to utilize our database are early-stage and pre-revenue, LSN aimed to transition the hefty up-front cost to a monthly, lower-cost plan. Our new subscription options are shown below:

Standard:

  • $300/month or $3K/year up-front
  • Minimum 6 months commitment

Premier (Recommended):

  • $500/month or $5K/year up-front
  • Includes 50% off ALL RESI Registrations for the duration of the subscription (excludes IPC)
  • Minimum 6 months commitment

To learn more about this database, please contact your Business Development Manager at Life Science Nation and we would be happy to walk you through the database and help answer any questions or concerns you may have!

Life Science Nation Business Development Team
International
East Coast (USA) & China
Midwest (USA)
& Canada
West Coast  (USA)
Cam_Headshot_new
Greg Mannix
Vice President International Business Development
Book a Meeting
Email Me
Candice He
VP, Business Development & Global Investment Strategist
Book a Meeting
Email Me
Antoinette Lowre
Manager of Business Development
Book a Meeting
Email Me
Cameron Hurlburt
Manager of Business Development
Book a Meeting
Email Me

RESI-Boston-2023-September-1100px-w

Confirmed Attendees for RESI Boston September. Join them with the Early Bird Rate.

By Antoinette Lowre, Manager of Business Development, LSN

RESI Boston September will continue with our hybrid format of 1-day in person at the Boston Park Plaza, followed by 2-days of virtual partnering. Monday, September 18 will feature our Investor Panels (check them out here), along with entrepreneur workshops led by industry expert service providers, and our popular Innovator’s Pitch Challenge (IPC) sessions. All alongside one-on-one partnering meetings from 8am-5pm.

We’re expecting over 300 more investors and strategic partners interested in partnering with early-stage life science companies to join us. Below are the confirmed investor attendees who will be at RESI Boston, September 18-20.

CI-07272023

Click Here to See More Investors

In addition to the 300+ investors, we are anticipating 300+ startups looking to raise capital and find providers for services they may need.

CC-07272023

SAVE $300 on your registration with the Early Bird Rate, ending tomorrow Friday, July 28th. Register now to join the RESI community this fall! The registration options are as followed:

Standard 3-day
(Sept. 18-20)
Virtual 2-day
(Sept. 19-20)
STARTUP $1,695 $1,995 $995 $1,195
Add the Premier Package* to view the full investor profiles, including contact information.
SERVICE PROVIDER $2,195 $2,495 $1,295 $1,495
EXHIBITOR $4,390 $4,990 Includes Two 3-Day Standard Tickets (Value: $4,990) and an Exhibition Table (Sept. 18) View RESI Sponsorship Brochure

RESI-Boston-2023-September-1100px-w

Mastering the Art of Partnering: A Roadmap for Startup Success

By Dennis Ford, Founder and CEO of Life Science Nation, Creator of the RESI Conference Series

In the competitive entrepreneurship landscape, startups often need help distinguishing themselves from the competition; they are in a race to stand out amongst the sea of meeting requests the partners receive. Investors and licensing partners continuously lament the need for startups to develop concise, cogent, and compelling messaging that nets out their value proposition and sheds some light on the team and technology.

The problem lies in the cookie-cutter, problem-solution, market-oriented pitch decks that often fail to convey a strong personal narrative and compelling story. A startup must realize it is essentially a numbers game when they embark on a global partnering initiative. They must engage in dialogue with hundreds of potential partners to find the few that will participate in the round.  To start the dialogue, you need to secure a constant flow of meetings with partners who fit your stage of development and product. Therein lies the rub, how does a startup generate a pipeline of meetings with the right players?

Crafting a Compelling Story

Startup founders must recognize that potential investors and licensing partners invest in people before they invest in products or services. Startups must recognize the immense importance of weaving a compelling story that captivates the hearts and minds of potential partners. They should build a strong personal narrative highlighting their passion and vision. This narrative should highlight the founder’s journey, the team’s expertise, and the milestones achieved, backed by validated data. A strong personal narrative resonates with investors and partners, setting the foundation for a meaningful relationship.

Knowing Your Target Audience

In the dynamic world of entrepreneurship, understanding the target audience is key to crafting an effective brand message. Entrepreneurs must identify the ten categories of investors and licensing partners that align with their stage of development and product. Tailoring the pitch and messaging to cater to potential partners’ specific needs and interests significantly increases the chances of securing valuable meetings and partnerships. A concise tagline and compelling elevator pitch enable investors to assess the startup’s value proposition swiftly, paving the way for further engagement.

Making it Easy to Say Yes

A key principle of business development is making it easy for potential partners to say yes to a meeting. Startups should proactively present the “value add” of their founder, team, and technology. Anticipating and addressing potential partner needs and concerns demonstrates professionalism and builds trust. By providing researched, relevant information, startups improve their chances of moving forward in the partnering process.

Embrace the Global Arena

Founders must recognize that staying in their geographic regions limits the number of opportunities, thus hindering the number of partners to engage with. Breaking free from geographic limitations opens the startup to wider opportunities. Expanding globally requires a strategic game plan and sufficient resources to execute a global campaign and roadshow. Adopting and understanding rudimentary sales and marketing tactics, such as identifying potential partners and establishing a meeting pipeline, is essential to achieving success on an international scale.

Patience and Persistence

Partnering is a journey that demands both patience and persistence. The partnering process is not an overnight success story. It often takes between 9 to 18 months to establish successful partnerships. Startup teams should be prepared for the ebb and flow of partner meetings while maintaining an ongoing pipeline. A dedicated staff member focused on scheduling meetings with potential partners and utilizing a Customer Relationship Management (CRM) system to track and manage the target list can help keep the process on track. LSN has just announced a Global Campaign Management product integrating the LSN partnering database with the Salesforce CRM.

Mastering the art of partnering is a critical aspect of startup success. Entrepreneurs can significantly enhance their chances of securing essential partnerships by developing a compelling storyline, understanding their target audience, expanding from regional to global, and dedicating resources to meeting engagement. Above all, patience and persistence are vital traits needed to navigate a successful global partnering campaign.

RESI-Boston-2023-September-1100px-w

 Clinials + LSN Educational Workshop = RESI Innovator’s Pitch Challenge Success

Maree-BeareMaree Beare Interview with Maree Beare, Founder at Clinials

By Caitlin Dolegowski, Marketing Manager, LSN

CaitiCaitlin Dolegowski

Maree Beare, Founder at Clinials, is a sector leader in HealthTec, FemTech and BioTech innovation. In 2021, Maree launched her second innovation, a BioTech company Clinials. Clinials is an AI-Driven clinical trial participant recruitment platform based in Brisbane, Australia, and a member of BEDA (Brisbane Economic Development Agency). Maree speaks with us about being a part of BEDA’s MedTech Accelerator cohort and her introduction to Life Science Nation followed by her eventual second-place finish in the Innovator’s Pitch Challenge at RESI Boston June earlier this summer.

RESI-Boston-2023-September-1100px-w